Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Net Margin (2018 - 2025)

Historic Net Margin for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to 153861.54%.

  • Precision Biosciences' Net Margin fell 1504295900.0% to 153861.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 12322.06%, marking a year-over-year decrease of 123216700.0%. This contributed to the annual value of 38.57% for FY2023, which is 1157400.0% up from last year.
  • Latest data reveals that Precision Biosciences reported Net Margin of 153861.54% as of Q3 2025, which was down 1504295900.0% from 117327.78% recorded in Q2 2025.
  • Precision Biosciences' 5-year Net Margin high stood at 50.96% for Q2 2024, and its period low was 153861.54% during Q3 2025.
  • Its 5-year average for Net Margin is 18621.27%, with a median of 114.31% in 2021.
  • Per our database at Business Quant, Precision Biosciences' Net Margin surged by 30649600bps in 2021 and then crashed by -1504295900bps in 2025.
  • Precision Biosciences' Net Margin (Quarter) stood at 484.52% in 2021, then soared by 82bps to 85.5% in 2022, then surged by 53bps to 40.57% in 2023, then crashed by -9074bps to 3721.63% in 2024, then plummeted by -4034bps to 153861.54% in 2025.
  • Its Net Margin stands at 153861.54% for Q3 2025, versus 117327.78% for Q2 2025 and 72906.9% for Q1 2025.